Oral human papillomavirus infection: Differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014

Annals of Internal Medicine

Volumn 167, Issue 10, 2017, Pages 714-724

  Sonawane, Kalyani ^a   Suk, Ryan ^a   Chiao, Elizabeth Y ^b   Chhatwal, Jagpreet ^c   Qiu, Peihua ^d   Wilkin, Timothy ^e   Nyitray, Alan G ^f   Sikora, Andrew G ^g   Deshmukh, Ashish A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Department of Biostatistics ^*  (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; HEMOGLOBIN BETA CHAIN;

ADULT; AGED; ARTICLE; CANNABIS USE; CLINICAL EVALUATION; COITUS; CONCURRENT SEXUAL PARTNERSHIP; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH INFECTION; ORAL SEX; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUALITY; SMOKE; SMOKING; WART VIRUS; ADOLESCENT; ETHNOLOGY; GYNECOLOGIC DISEASE; HOMOSEXUALITY; MALE GENITAL SYSTEM DISEASE; MOUTH DISEASE; NUTRITION; PHARYNX DISEASE; RISK FACTOR; SEX RATIO; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HOMOSEXUALITY; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; NUTRITION SURVEYS; PAPILLOMAVIRUS INFECTIONS; PHARYNGEAL DISEASES; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 85035045439     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-1363     Document Type: Article

References (35)

1. Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, et al. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015;136:2752-60. [PMID: 25043222] doi:10.1002/ijc.29082
2. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus-associated cancers- United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2016;65: 661-6. [PMID: 27387669] doi:10.15585/mmwr.mm6526a1
3. Mourad M, Jetmore T, Jategaonkar AA, Moubayed S, Moshier E, Urken ML. Epidemiological trends of head and neck cancer in the United States: a SEER population study. J Oral Maxillofac Surg. 2017. [PMID: 28618252] doi:10.1016/j.joms.2017.05.008
4. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235-42. [PMID: 26351338] doi:10 .1200/JCO.2015.61.6995
5. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-301. [PMID: 21969503] doi:10.1200/JCO.2011.36.4596
6. Hirth JM, Chang M, Resto VA; HPV Study Group. Prevalence of oral human papillomavirus by vaccination status among young adults (18-30 years old). Vaccine. 2017;35:3446-51. [PMID: 28526331] doi:10.1016/j.vaccine.2017.05.025
7. Voss DS, Wofford LG. Human papillomavirus vaccine uptake in adolescent boys: an evidence review. Worldviews Evid Based Nurs. 2016;13:390-5. [PMID: 27458811] doi:10.1111/wvn.12172
8. Lu PJ, Yankey D, Jeyarajah J, O'Halloran A, Elam-Evans LD, Smith PJ, et al. HPV vaccination coverage of male adolescents in the United States. Pediatrics. 2015;136:839-49. [PMID: 26504124] doi:10.1542 /peds.2015-1631
9. Johnson KL, Lin MY, Cabral H, Kazis LE, Katz IT. Variation in human papillomavirus vaccine uptake and acceptability between female and male adolescents and their caregivers. J Community Health. 2017;42:522-32. [PMID: 27778139] doi:10.1007/s10900-016-0284-5
10. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey 2013-2014 data documentation, codebook, and frequencies. 2017. Accessed at wwwn.cdc.gov/Nchs /Nhanes/2013-2014/DIQ-H.htm on 19 September 2017.
11. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307:693-703. [PMID: 22282321] doi:10.1001 /jama.2012.101
12. Munõz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-27. [PMID: 12571259]
13. Deshmukh AA, Tanner RJ, Luetke MC, Hong YR, Sonawane Deshmukh K, Mainous AG 3rd. Prevalence and risk of penile human papillomavirus infection: evidence from the National Health and Nutrition Examination Survey 2013-2014. Clin Infect Dis. 2017;64: 1360-6. [PMID: 28205678] doi:10.1093/cid/cix159
14. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis. 2011;204:566-73. [PMID: 21791659] doi:10 .1093/infdis/jir341
15. Kreimer AR, Pierce Campbell CM, Lin HY, Fulp W, Papenfuss MR, Abrahamsen M, et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382:877-87. [PMID: 23827089] doi:10.1016/S0140-6736(13) 60809-0
16. Wood ZC, Bain CJ, Smith DD, Whiteman DC, Antonsson A. Oral human papillomavirus infection incidence and clearance: a system-atic review of the literature. J Gen Virol. 2017;98:519-26. [PMID: 28150575] doi:10.1099/jgv.0.000727
17. Pierce Campbell CM, Kreimer AR, Lin HY, Fulp W, O'Keefe MT, Ingles DJ, et al. Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study. Cancer Prev Res (Phila). 2015;8:190-6. [PMID: 25575501] doi:10.1158/1940-6207 .CAPR-14-0296
18. Liu F, Hang D, Deng Q, Liu M, Xi L, He Z, et al. Concurrence of oral and genital human papillomavirus infection in healthy men: a population-based cross-sectional study in rural China. Sci Rep. 2015; 5:15637. [PMID: 26503510] doi:10.1038/srep15637
19. Steinau M, Gorbach P, Gratzer B, Braxton J, Kerndt PR, Crosby RA, et al. Concordance between anal and oral human papillomavirus infections among young men who have sex with men. J Infect Dis. 2017;215:1832-5. [PMID: 28505338] doi:10.1093/infdis/jix232
20. Mbulawa ZZ, Johnson LF, Marais DJ, Coetzee D, Williamson AL. Risk factors for oral human papillomavirus in heterosexual couples in an African setting. J Infect. 2014;68:185-9. [PMID: 24184808] doi:10 .1016/j.jinf.2013.10.012
21. Vogt SL, Gravitt PE, Martinson NA, Hoffmann J, D'Souza G. Concordant oral-genital HPV infection in South Africa couples: evidence for transmission. Front Oncol. 2013;3:303. [PMID: 24377087] doi:10 .3389/fonc.2013.00303
22. Beachler DC, Sugar EA, Margolick JB, Weber KM, Strickler HD, Wiley DJ, et al. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIVuninfected adults. Am J Epidemiol. 2015;181:40-53. [PMID: 25480823] doi:10.1093/aje/kwu247
23. Hernandez BY, Wilkens LR, Zhu X, Thompson P, McDuffie K, Shvetsov YB, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis. 2008;14:888-94. [PMID: 18507898] doi:10.3201/eid1406.070616
24. Sikora AG, Morris LG, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men. Arch Otolaryngol Head Neck Surg. 2009;135:402-5. [PMID: 19380365] doi:10 .1001/archoto.2009.19
25. Wawer MJ, Tobian AA, Kigozi G, Kong X, Gravitt PE, Serwadda D, et al. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet. 2011;377:209-18. [PMID: 21216000] doi: 10.1016/S0140-6736(10)61967-8
26. Chaturvedi AK, Graubard BI, Broutian T, Pickard RK, Tong ZY, Xiao W, et al. NHANES 2009-2012 findings: association of sexual behaviors with higher prevalence of oral oncogenic human papillomavirus infections in U.S. Men. Cancer Res. 2015;75:2468-77. [PMID: 25873485] doi:10.1158/0008-5472.CAN-14-2843
27. D'Souza G, Wentz A, Kluz N, Zhang Y, Sugar E, Youngfellow RM, et al. Sex differences in risk factors and natural history of oral human papillomavirus infection. J Infect Dis. 2016;213:1893-6. [PMID: 26908748] doi:10.1093/infdis/jiw063
28. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26: 612-9. [PMID: 18235120] doi:10.1200/JCO.2007.14.1713
29. Louie KS, Mehanna H, Sasieni P. Trends in head and neck cancers in England from 1995 to 2011 and projections up to 2025. Oral Oncol. 2015;51:341-8. [PMID: 25619734] doi:10.1016/j.oraloncology .2015.01.002
30. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14:467-75. [PMID: 15734974]
31. Fakhry C, Gillison ML, D'Souza G. Tobacco use and oral HPV-16 infection. JAMA. 2014;312:1465-7. [PMID: 25291584] doi:10.1001 /jama.2014.13183
32. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34: J258-65. [PMID: 20042314] doi:10.1016/j.jaut.2009.12.003
33. Castle PE. How does tobacco smoke contribute to cervical carcinogenesis? [Letter]. J Virol. 2008;82:6084-5. [PMID: 18497423] doi: 10.1128/JVI.00103-08
34. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263-9. [PMID: 19320589] doi: 10.1086/597755
35. Wilkin T, Chen H, Cespedes M, Paczuski P, Godfrey C, et al. ACTG A5298: a phase 3 trial of the quadrivalent HPV vaccine in older HIV+ adults. Presented at Conference on Retroviruses and Opportunistic Infections 2016, Boston, Massachusetts, 22-25 February 2016. Abstract no. 161.